Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,192.22 16.25 0.51%
FTSE 100 6,711.85 37.11 0.56%
DAX 9,575.69 31.50 0.33%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,562.80 53.16 0.24%

Amgen To Present At The Goldman Sachs 34th Annual Global Healthcare Conference



Amgen To Present At The Goldman Sachs 34th Annual Global Healthcare Conference

PR Newswire

THOUSAND OAKS, Calif., June 6, 2013

THOUSAND OAKS, Calif., June 6, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will
present at the Goldman Sachs 34^th Annual ^ Global Healthcare Conference on
Tuesday, June 11, 2013, at the Terranea Resort, Rancho Palos Verdes, Calif.,
beginning at 11:20 a.m. PDT. Jonathan M. Peacock, executive vice president and
chief financial officer at Amgen, and Anthony C. Hooper, executive vice
president of Global Commercial Operations at Amgen, will present at the
conference. Live audio of the presentation can be accessed from the Events
Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the
webcast will also be available on Amgen's website for 90 days following the
event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe, effective
medicines from lab to manufacturing plant to patient. Amgen therapeutics have
changed the practice of medicine, helping people around the world in the fight
against serious illnesses. With a deep and broad pipeline of potential new
medicines, Amgen remains committed to advancing science to dramatically
improve people's lives. For more information, visit www.amgen.com and follow
us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

SOURCE Amgen

Website: http://www.amgen.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement